|
US6887707B2
(en)
*
|
1996-10-28 |
2005-05-03 |
University Of Washington |
Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA
|
|
NZ507848A
(en)
*
|
1996-10-28 |
2005-01-28 |
Univ Washington |
Method of increasing the mutation rate of a virus in a non-human by administering an RNA nucleoside analogue to a virally infected cell
|
|
US6423695B1
(en)
*
|
1998-01-13 |
2002-07-23 |
Ribapharm, Inc. |
Cytokine related treatments of disease
|
|
EP1165127B1
(en)
*
|
1999-03-26 |
2008-12-31 |
Walter Reed Army Institute of Research |
Multivalent dengue virus vaccine
|
|
AU8038400A
(en)
*
|
1999-09-09 |
2001-04-10 |
Zymetx, Inc. |
Method of treatment of influenza
|
|
WO2001030989A2
(en)
*
|
1999-10-27 |
2001-05-03 |
Cytos Biotechnology Ag |
Method for creating divergent populations of nucleic acid molecules and proteins
|
|
US7638496B2
(en)
|
2000-02-15 |
2009-12-29 |
Valeant Pharmaceuticals North America |
Nucleoside analogs with carboxamidine modified monocyclic base
|
|
KR20030005197A
(ko)
|
2000-02-18 |
2003-01-17 |
샤이어 바이오켐 인코포레이티드 |
뉴클레오시드유도체를 이용한 플라비바이러스 감염의 치료또는 예방 방법
|
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
EP1736478B1
(en)
*
|
2000-05-26 |
2015-07-22 |
IDENIX Pharmaceuticals, Inc. |
Methods and compositions for treating flaviviruses and pestiviruses
|
|
WO2002032920A2
(en)
|
2000-10-18 |
2002-04-25 |
Pharmasset Limited |
Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
|
|
SK286630B6
(sk)
*
|
2001-01-22 |
2009-02-05 |
Merck & Co., Inc. |
Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
|
|
US8481712B2
(en)
|
2001-01-22 |
2013-07-09 |
Merck Sharp & Dohme Corp. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
WO2002069903A2
(en)
*
|
2001-03-06 |
2002-09-12 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
WO2003018030A1
(en)
*
|
2001-08-24 |
2003-03-06 |
Koronis Pharmaceuticals, Inc. |
Mutagenic nucleoside analogs for the treatment of viral disease
|
|
US20040006002A1
(en)
*
|
2001-09-28 |
2004-01-08 |
Jean-Pierre Sommadossi |
Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside
|
|
US7049303B2
(en)
*
|
2001-11-07 |
2006-05-23 |
Medical Research Council |
Inhibition of viruses
|
|
US20040138170A1
(en)
*
|
2002-03-06 |
2004-07-15 |
Montgomery John A. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
NZ537662A
(en)
*
|
2002-06-28 |
2007-10-26 |
Idenix Cayman Ltd |
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
|
US7608600B2
(en)
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
|
CN1678326A
(zh)
*
|
2002-06-28 |
2005-10-05 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2'－c－甲基－3'－o－l－缬氨酸酯核糖呋喃基胞苷
|
|
AU2003261231A1
(en)
|
2002-07-26 |
2004-02-16 |
Chiron Corporation |
Modified small interfering rna molecules and methods of use
|
|
LT1576138T
(lt)
|
2002-11-15 |
2017-06-26 |
Idenix Pharmaceuticals Llc |
2`-šakoti nukleozidai derinyje su interferonu ir flaviviridae mutacija
|
|
AU2003300901A1
(en)
*
|
2002-12-12 |
2004-06-30 |
Idenix (Cayman) Limited |
Process for the production of 2'-branched nucleosides
|
|
WO2004084796A2
(en)
*
|
2003-03-28 |
2004-10-07 |
Pharmasset Ltd. |
Compounds for the treatment of flaviviridae infections
|
|
WO2005018330A1
(en)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
|
WO2005019424A2
(en)
*
|
2003-08-18 |
2005-03-03 |
Wright State University |
Retroviral vector and cell-based assay for measuring the mutation rate of retroviruses employing same
|
|
CA2600886A1
(en)
|
2005-03-08 |
2006-09-14 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
|
EP1869012A1
(en)
*
|
2005-04-05 |
2007-12-26 |
Boehringer Ingelheim International Gmbh |
Substituted benzylimidazoles useful for the treatment of inflammatory diseases
|
|
ES2422290T3
(es)
*
|
2005-12-23 |
2013-09-10 |
Idenix Pharmaceuticals Inc |
Procedimiento para preparar un producto intermedio sintético para la preparación de nucleósidos ramificados
|
|
EP1859690A1
(en)
|
2006-05-26 |
2007-11-28 |
Health Concern B.V. |
Premix for cholesterol lowering food products
|
|
WO2009043096A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Arana Therapeutics (Vic) Pty Ltd |
Improved method for mutagenesis
|
|
MX2010004995A
(es)
*
|
2007-11-29 |
2010-05-20 |
Boehringer Ingelheim Int |
Derivados de amidas del acido 6,7-dihidro-5h-imidazo[1,2-a]imidazo l-3-carboxilico.
|
|
JP4621926B2
(ja)
*
|
2008-07-24 |
2011-02-02 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸、核酸プローブ、マルチラベル化核酸プローブ、マルチラベル化核酸プローブの製造方法および標的核酸の検出方法
|
|
JP5146785B2
(ja)
*
|
2008-07-24 |
2013-02-20 |
国立大学法人九州大学 |
酵素基質修飾ヌクレオシド三リン酸誘導体
|
|
JP2012521359A
(ja)
*
|
2009-03-20 |
2012-09-13 |
アリオス バイオファーマ インク． |
置換されたヌクレオシドアナログおよびヌクレオチドアナログ
|
|
BRPI1012581A2
(pt)
|
2009-06-02 |
2016-03-29 |
Boehringer Ingelheim Int |
derivados de amidas de ácido 6, 7-di-hidro-5h-imidazol[1,2-a]imidazol-3-carboxílico
|
|
WO2010141330A1
(en)
|
2009-06-02 |
2010-12-09 |
Boehringer Ingelheim International Gmbh |
DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
|
|
JP5704481B2
(ja)
*
|
2010-01-22 |
2015-04-22 |
国立大学法人九州大学 |
核酸検出用キット
|
|
NZ607996A
(en)
|
2010-09-22 |
2014-07-25 |
Alios Biopharma Inc |
Substituted nucleotide analogs
|
|
EP2697242B1
(en)
|
2011-04-13 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
WO2012142093A2
(en)
|
2011-04-13 |
2012-10-18 |
Merck Sharp & Dohme Corp. |
2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
BR112013026345A2
(pt)
|
2011-04-13 |
2019-04-24 |
Merck Sharp & Dohe Corp. |
composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv
|
|
WO2013009735A1
(en)
|
2011-07-13 |
2013-01-17 |
Merck Sharp & Dohme Corp. |
5'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
|
|
US9408863B2
(en)
|
2011-07-13 |
2016-08-09 |
Merck Sharp & Dohme Corp. |
5′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
|
|
CA2860234A1
(en)
|
2011-12-22 |
2013-06-27 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
|
HK1206362A1
(zh)
|
2012-03-21 |
2016-01-08 |
Alios Biopharma, Inc. |
硫代氨基磷酸酯核苷酸前藥的固體形式
|
|
WO2013142157A1
(en)
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
US10278984B2
(en)
*
|
2014-05-02 |
2019-05-07 |
Nitor Therapeutics |
Guanosine as an immune potentiator mediated through toll receptors
|
|
WO2020081937A1
(en)
*
|
2018-10-19 |
2020-04-23 |
The University Of Chicago |
Methods and compositions for treating negative-sense single-stranded rna virus
|